Cervical Glycosaminoglycans and Extracellular Matrix Remodeling: New Insights and the Therapeutic Promise of Tafoxiparin
Cells · 2025
DOI: 10.3390/cells14241934 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2025. Verfasst von Wojciech Flis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, St. Adalbert's Hospital, Gdańsk Copernicus Healthcare Entity, Jana Pawła II 50, 80-462 Gdańsk, Poland. Hauptthemen laut MEDLINE: Extracellular Matrix, Glycosaminoglycans, Cervix Uteri, Phenylpropionates. Die Arbeit nennt 195 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cervical ripening is a multifaceted process involving endocrine, inflammatory, and biomechanical signals that act on the cervical extracellular matrix. While previous reviews have focused on hormonal and immune mechanisms, the specific role of cervical glycosaminoglycans (GAGs)—particularly hyaluronan and heparan sulfate—has received limited dedicated attention. This review addresses that gap by exploring how these GAGs function as integrators of hormonal cues, immune activation, and extracellular matrix remodeling during pregnancy and labour. We conducted a narrative synthesis of experimental, translational, and clinical studies on GAG composition, metabolism, and signaling, with particular attention to tafoxiparin, a heparan-sulfate-based compound with minimal anticoagulant activity. Available evidence suggests that alterations in hyaluronan and heparan sulfate content influence collagen disorganization, tissue hydration, immune cell infiltration, and prostaglandin production—collectively contributing to cervical softening and dilatation. Although tafoxiparin may replicate some actions of endogenous GAGs, current clinical data remain sparse and inconclusive. Thus, targeting cervical GAG biology represents a mechanistic yet still investigational strategy, requiring further studies to determine its therapeutic value.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, St. Adalbert's Hospital, Gdańsk Copernicus Healthcare Entity, Jana Pawła II 50, 80-462 Gdańsk, Poland.
- Department of Perinatology, Gynecology and Gynecologic Oncology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Łukasiewicza 1, 85-821 Bydgoszcz, Poland.
- Department of Pathophysiology, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, M. Curie-Skłodowskiej 9, 85-094 Bydgoszcz, Poland.
ORCID-Profile: Wojciech Flis, Mateusz Wartęga, Julia Sowińska, Maciej W Socha
Zitieren
APA
Flis, W., Wartęga, M., Sowińska, J., & Socha, M. W. (2025). Cervical Glycosaminoglycans and Extracellular Matrix Remodeling: New Insights and the Therapeutic Promise of Tafoxiparin. Cells. https://doi.org/10.3390/cells14241934
Vancouver
Flis W, Wartęga M, Sowińska J, Socha MW. Cervical Glycosaminoglycans and Extracellular Matrix Remodeling: New Insights and the Therapeutic Promise of Tafoxiparin. Cells. 2025. doi:10.3390/cells14241934
BibTeX
@article{Flis2025,
author = {Flis, Wojciech and Wartęga, Mateusz and Sowińska, Julia and Socha, Maciej W},
title = {Cervical Glycosaminoglycans and Extracellular Matrix Remodeling: New Insights and the Therapeutic Promise of Tafoxiparin},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14241934}
}
EUVIMED